Amarillo Biosciences (AMAR) Announces Plan to Open Asia Operations Center in Taipei, Taiwan
6/26/2012 9:10:39 AM
More...
|
CytoPharm and Amarillo Biosciences (AMAR) Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients With Mild Fibrosis
6/15/2012 7:50:48 AM
More...
|
Amarillo Biosciences (AMAR) Appoints Dr. Stephen Chen as Chairman and CEO
2/23/2012 7:31:29 AM
More...
|
Amarillo Biosciences (AMAR)' Live Interview Available on ChartPoppers.com
11/3/2011 8:26:56 AM
More...
|
Amarillo Biosciences (AMAR) Issues Corporate Update
10/17/2011 11:03:39 AM
More...
|
Amarillo Biosciences (AMAR) Teams with Animal Shelters to Improve Health and Enhance Immunity of Cats and Dogs
10/5/2011 1:23:22 PM
More...
|
Amarillo Biosciences (AMAR) Teams With Colorado Serum Company to Manufacture Immune-Boosting Bovine Protein Extract for Animal and Human Health Markets
8/23/2011 8:16:09 AM
More...
|
Amarillo Biosciences (AMAR) Teams With Bio-Stasis International to Launch Dietary Supplement Virapress
7/20/2011 8:41:17 AM
More...
|
Amarillo Biosciences (AMAR) Releases Corporate Progress Report
7/11/2011 8:46:12 AM
More...
|
Amarillo Biosciences (AMAR)' CEO Does Live Interview on ChartPoppers.com
1/18/2011 8:49:11 AM
More...
|
|